title: Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones.
abstract: Longer treatment period in distraction osteogenesis (DO) leads to more frequent complications. We developed a new technique of transplantation of culture expanded bone marrow cells (BMC) and platelet rich plasma (PRP) in DO of the long bones. Retrospective comparative study was conducted between the bones treated with and without BMC and PRP in DO to assess the efficacy of this new technique of transplantation. Ninety-two bones (46 patients) that were lengthened in our hospital and followed up until removal of the pins were divided into two groups according to the cell (BMC+PRP) treatment. The BMC-PRP(+) group consisted of 32 bones (14 femora, 18 tibiae) in 17 patients (10 boys and 7 girls), while the BMC-PRP(-) group consisted of 60 bones (25 femora, 35 tibiae) in 29 patients (13 boys and 16 girls). The clinical outcome including the age at operation, amount of length gained, the healing index, the delay in consolidation, and complications were compared between the two groups. The healing between the femoral and the tibial lengthening was also assessed. The average age at operation was 15.8 years in the BMC-PRP(+) group and 15.5 years in the BMC-PRP(-) group. Although there were no significant differences in the age at operation and the length gained between the two groups, the average healing indices of the BMC-PRP(+) group in short stature and in limb length discrepancy were significantly lower than those of the BMC-PRP(-) group (P=0.0019 and P=0.0031, respectively). A delay in consolidation was seen in 45% of the BMC-PRP(-) group but never observed in the BMC-PRP(+) group (P<0.0001). The rate of complications was 23% of the BMC-PRP(-) group and only 6% of the BMC-PRP(+) group (P=0.0406). The femoral lengthening showed significantly faster healing than the tibial lengthening by the BMC and PRP transplantation (P=0.0004) In conclusion, transplantation of BMC and PRP shortened the treatment period and reduced associated complications by accelerating new bone formation in DO.
authors.affiliation: Department of Orthopaedic Surgery, Nagoya University School of Medicine, Nagoya, Aichi 466-8550, Japan. hkitoh@med.nagoya-u.ac.jp
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kitoh
authors.forename: Takahiko
authors.initials: T
authors.lastname: Kitakoji
authors.forename: Hiroki
authors.initials: H
authors.lastname: Tsuchiya
authors.forename: Mitsuyasu
authors.initials: M
authors.lastname: Katoh
authors.forename: Naoki
authors.initials: N
authors.lastname: Ishiguro
mesh_terms: D000293:Adolescent; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D005260:Female; D005269:Femur / Q000601:surgery*; D006801:Humans; D008297:Male; D019857:Osteogenesis, Distraction; D017713:Platelet Transfusion; D053657:Platelet-Rich Plasma; D011183:Postoperative Complications / Q000517:prevention & control; D012189:Retrospective Studies; D013977:Tibia / Q000601:surgery*